MX2023007429A - Uso como agonista selectivo de receptor de melanocortina-4. - Google Patents
Uso como agonista selectivo de receptor de melanocortina-4.Info
- Publication number
- MX2023007429A MX2023007429A MX2023007429A MX2023007429A MX2023007429A MX 2023007429 A MX2023007429 A MX 2023007429A MX 2023007429 A MX2023007429 A MX 2023007429A MX 2023007429 A MX2023007429 A MX 2023007429A MX 2023007429 A MX2023007429 A MX 2023007429A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor
- malanocortin
- selective agonist
- mc4r
- melanocortin
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 2
- 102000001796 Melanocortin 4 receptors Human genes 0.000 abstract 2
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se relaciona al uso de un compuesto de la fórmula química 1 o una sal farmacéuticamente aceptable del mismo como un agonista selectivo para el receptor de melanocortina-4 (MC4R).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20200180505 | 2020-12-22 | ||
| PCT/KR2021/019500 WO2022139406A1 (ko) | 2020-12-22 | 2021-12-21 | 멜라노코르틴-4 수용체의 선택적 항진제로서의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023007429A true MX2023007429A (es) | 2023-07-03 |
Family
ID=82158145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023007429A MX2023007429A (es) | 2020-12-22 | 2021-12-21 | Uso como agonista selectivo de receptor de melanocortina-4. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240091235A1 (es) |
| EP (1) | EP4265255A1 (es) |
| JP (1) | JP2024502281A (es) |
| KR (1) | KR20220090450A (es) |
| CN (1) | CN116782877A (es) |
| AU (1) | AU2021409684A1 (es) |
| CA (1) | CA3202315A1 (es) |
| IL (1) | IL303822A (es) |
| MX (1) | MX2023007429A (es) |
| TW (1) | TWI832128B (es) |
| WO (1) | WO2022139406A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU766191B2 (en) * | 1999-06-04 | 2003-10-09 | Merck & Co., Inc. | Substituted piperidines as melanocortin-4 receptor agonists |
| US7157463B2 (en) * | 2001-01-23 | 2007-01-02 | Eli Lilly And Company | Substituted piperidines/piperazines as melanocortin receptor agonists |
| JP4795965B2 (ja) * | 2003-11-12 | 2011-10-19 | エルジー・ライフ・サイエンシーズ・リミテッド | メラノコルチン受容体のアゴニスト |
| UA99555C2 (en) * | 2008-11-12 | 2012-08-27 | Элджи Лайф Саенсез Лтд. | Melanocortin receptor agonists |
| KR102485182B1 (ko) * | 2019-11-07 | 2023-01-06 | 주식회사 엘지화학 | 멜라노코르틴-4 수용체 작용제 |
-
2021
- 2021-12-21 CN CN202180086020.3A patent/CN116782877A/zh active Pending
- 2021-12-21 IL IL303822A patent/IL303822A/en unknown
- 2021-12-21 MX MX2023007429A patent/MX2023007429A/es unknown
- 2021-12-21 WO PCT/KR2021/019500 patent/WO2022139406A1/ko active Application Filing
- 2021-12-21 TW TW110147939A patent/TWI832128B/zh active
- 2021-12-21 CA CA3202315A patent/CA3202315A1/en active Pending
- 2021-12-21 JP JP2023538838A patent/JP2024502281A/ja active Pending
- 2021-12-21 EP EP21911473.3A patent/EP4265255A1/en active Pending
- 2021-12-21 KR KR1020210183897A patent/KR20220090450A/ko not_active Application Discontinuation
- 2021-12-21 US US18/258,653 patent/US20240091235A1/en active Pending
- 2021-12-21 AU AU2021409684A patent/AU2021409684A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TWI832128B (zh) | 2024-02-11 |
| WO2022139406A1 (ko) | 2022-06-30 |
| CN116782877A (zh) | 2023-09-19 |
| CA3202315A1 (en) | 2022-06-30 |
| EP4265255A1 (en) | 2023-10-25 |
| AU2021409684A1 (en) | 2023-07-06 |
| IL303822A (en) | 2023-08-01 |
| TW202233610A (zh) | 2022-09-01 |
| JP2024502281A (ja) | 2024-01-18 |
| KR20220090450A (ko) | 2022-06-29 |
| US20240091235A1 (en) | 2024-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1496892A4 (en) | 1H-BENZO (F) INDAZOL-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | |
| UA94833C2 (en) | Substituted bicyclolactams | |
| CY1112011T1 (el) | Παραγωγα αζαδικυκλο (3.1.0) εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης | |
| MX2007005694A (es) | Nuevos derivados de betulina, preparacion y uso de los mismos. | |
| EA200702497A1 (ru) | Замещенные арилпиразолы для применения против паразитов | |
| MY146924A (en) | Substituted imidazoheterocycles | |
| TNSN05328A1 (en) | (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists | |
| EA200870079A1 (ru) | Замещенные имидазолы и их применение в качестве пестицидов | |
| TN2009000107A1 (en) | New sulfonamide derivatives as bradykinin antagonists | |
| MY179516A (en) | Urea derivative or pharmacologically acceptable salt thereof | |
| MXPA05013474A (es) | Derivados de quinolilamida como antagonistas de ccr-5. | |
| MX2009007482A (es) | Agentes antiparasitarios. | |
| MX2021000093A (es) | Antagonistas del receptor de tipo toll 7/8 (tlr7/8) y usos de los mismos. | |
| TW200604185A (en) | Chemical compounds | |
| ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| MX2020002430A (es) | Compuestos inhibidores del receptor 1 del acido lisofosfatidico (lpar1). | |
| MX2016015467A (es) | Derivados de carbonitrilo como moduladores selectivos del receptor de androgenos. | |
| TW200716597A (en) | Novel piperidine-substituted indoles | |
| MA37501B1 (fr) | Composés de pyrazole utilisés en tant qu'inhibiteurs de sglt1 | |
| MA50093B1 (fr) | Composé pentacyclique | |
| MX362919B (es) | Moduladores del receptor acoplado a proteína-g 120 (gpr120) de ácido biciclo-[2.2.1]. | |
| MXPA04005426A (es) | Derivados de pirazol de anillos fuisionados. | |
| MY152557A (en) | 3-aminocyclopentanecarboxamides as chemokine receptor modulators | |
| WO2008133344A3 (en) | Piperidine derivative and use thereof | |
| EP1617806A4 (en) | SELECTIVE SPIROCYCLIC GLUCOCORTICOID RECEPTOR MODULATORS |